Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

BACKGROUND GII.4 noroviruses are a significant source of acute gastroenteritis worldwide, causing the majority of human norovirus outbreaks. Evolution of the GII.4 major capsid protein occurs rapidly, resulting in the emergence of new strains that produce successive waves of pandemic disease. A new pandemic isolate, GII.4 2012 Sydney, largely replaced previously circulating strains in late 2012. We compare the antigenic properties of GII.4 2012 Sydney with previously circulating strains. METHODS To determine whether GII.4-2012 Sydney is antigenically different from recently circulating strains GII.4-2006 Minerva and GII.4-2009 New Orleans in previously identified blockade epitopes, we compared reactivity and blockade profiles of GII.4-2006, GII.4-2009, and GII.4-2012 virus-like particles in surrogate neutralization/blockade assays using monoclonal antibodies and human polyclonal sera. RESULTS Using monoclonal antibodies that map to known blockade epitopes in GII.4-2006 and GII.4-2009 and human outbreak polyclonal sera, we demonstrate either complete loss or significantly reduced reactivity and blockade of GII.4.2012 compared to GII.4-2006 and GII.4-2009. CONCLUSIONS GII.4-2012 Sydney is antigenically different from GII.4-2006 Minerva and GII.4-2009 New Orleans in at least 2 key blockade epitopes. Viral evolution in key potential neutralization epitopes likely allowed GII.4-2012 to escape from human herd immunity and emerge as the new predominant strain.

[1]  J. Vinjé,et al.  Emergence of New Norovirus Strain GII.4 Sydney — United States, 2012 , 2013, MMWR. Morbidity and mortality weekly report.

[2]  J. Vinjé,et al.  Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  J. Vinjé,et al.  Notes from the Field: Emergence of New Norovirus Strain GII.4 Sydney - United States, 2012. , 2013 .

[4]  R. Baric,et al.  Emergence of a Norovirus GII.4 Strain Correlates with Changes in Evolving Blockade Epitopes , 2012, Journal of Virology.

[5]  J. Pearce,et al.  The Use of Intravenous Palivizumab for Treatment of Persistent RSV Infection in Children With Leukemia , 2012, Pediatrics.

[6]  M. Iturriza-Gómara,et al.  Molecular Evolution of GII-4 Norovirus Strains , 2012, PloS one.

[7]  M. Beltramello,et al.  Immunogenetic Mechanisms Driving Norovirus GII.4 Antigenic Variation , 2012, PLoS pathogens.

[8]  R. Baric,et al.  Genetic Mapping of a Highly Variable Norovirus GII.4 Blockade Epitope: Potential Role in Escape from Human Herd Immunity , 2011, Journal of Virology.

[9]  R. Baric,et al.  Monoclonal Antibody-Based Antigenic Mapping of Norovirus GII.4-2002 , 2011, Journal of Virology.

[10]  J. Vinjé,et al.  Novel Surveillance Network for Norovirus Gastroenteritis Outbreaks, United States , 2011, Emerging infectious diseases.

[11]  B. Sankaran,et al.  Structural Analysis of Histo-Blood Group Antigen Binding Specificity in a Norovirus GII.4 Epidemic Variant: Implications for Epochal Evolution , 2011, Journal of Virology.

[12]  P. White,et al.  Mechanisms of GII.4 norovirus evolution. , 2011, Trends in microbiology.

[13]  J. Vinjé,et al.  Updated norovirus outbreak management and disease prevention guidelines. , 2011, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[14]  V. Hytönen,et al.  Prevalence of norovirus GII‐4 antibodies in Finnish children , 2011, Journal of medical virology.

[15]  P. Pothier,et al.  Qualitative and Quantitative Analysis of the Binding of GII.4 Norovirus Variants onto Human Blood Group Antigens , 2011, Journal of Virology.

[16]  M. Widdowson,et al.  Foodborne Illness Acquired in the United States—Major Pathogens , 2011, Emerging infectious diseases.

[17]  R. Baric,et al.  Specificity and kinetics of norovirus binding to magnetic bead‐conjugated histo‐blood group antigens , 2010, Journal of applied microbiology.

[18]  R. Baric,et al.  Norovirus GII.4 Strain Antigenic Variation , 2010, Journal of Virology.

[19]  D. Graham,et al.  Serological correlate of protection against norovirus-induced gastroenteritis. , 2010, The Journal of infectious diseases.

[20]  X. Pang,et al.  Genetic and Phenotypic Characterization of GII-4 Noroviruses That Circulated during 1987 to 2008 , 2010, Journal of Virology.

[21]  K. Subbarao,et al.  Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. , 2010, The Journal of clinical investigation.

[22]  P. White,et al.  Rapid Evolution of Pandemic Noroviruses of the GII.4 Lineage , 2010, PLoS pathogens.

[23]  M. Iturriza-Gómara,et al.  Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding , 2009, Virology Journal.

[24]  K. Bok,et al.  Evolutionary Dynamics of GII.4 Noroviruses over a 34-Year Period , 2009, Journal of Virology.

[25]  R. Baric,et al.  Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations , 2008, Immunological reviews.

[26]  R. Hegde,et al.  Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. , 2008, Virology.

[27]  A. M. Hutson,et al.  Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus , 2008, Proceedings of the National Academy of Sciences.

[28]  R. Baric,et al.  Mechanisms of GII.4 Norovirus Persistence in Human Populations , 2008, PLoS medicine.

[29]  M. Iturriza-Gómara,et al.  Analysis of Amino Acid Variation in the P2 Domain of the GII-4 Norovirus VP1 Protein Reveals Putative Variant-Specific Epitopes , 2008, PloS one.

[30]  J. Siebenga,et al.  Food-borne viruses in Europe network report: the norovirus GII.4 2006b (for US named Minerva-like, for Japan Kobe034-like, for UK V6) variant now dominant in early seasonal surveillance. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[31]  R. Siezen,et al.  Epochal Evolution of GGII.4 Norovirus Capsid Proteins from 1995 to 2006 , 2007, Journal of Virology.

[32]  Yanjun Liu,et al.  Structural Basis for the Recognition of Blood Group Trisaccharides by Norovirus , 2007, Journal of Virology.

[33]  Norovirus activity--United States, 2006-2007. , 2007, MMWR. Morbidity and mortality weekly report.

[34]  K. Hedlund,et al.  Increase in norovirus activity reported in Europe. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[35]  S. Okitsu,et al.  Changing distribution of norovirus genotypes and genetic analysis of recombinant GIIb among infants and children with diarrhea in Japan , 2006, Journal of medical virology.

[36]  M. Estes,et al.  X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Roger I Glass,et al.  Norovirus classification and proposed strain nomenclature. , 2006, Virology.

[38]  Rowena A. Bull,et al.  Emergence of a New Norovirus Genotype II.4 Variant Associated with Global Outbreaks of Gastroenteritis , 2006, Journal of Clinical Microbiology.

[39]  M. Hardy,et al.  Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions. , 2005, The Journal of general virology.

[40]  Roger I Glass,et al.  Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus--United States, 2002. , 2004, The Journal of infectious diseases.

[41]  R. Baric,et al.  Binding of Norwalk Virus-Like Particles to ABH Histo-Blood Group Antigens Is Blocked by Antisera from Infected Human Volunteers or Experimentally Vaccinated Mice , 2002, Journal of Virology.

[42]  Roger I Glass,et al.  Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. , 2002, The Journal of infectious diseases.

[43]  J. Le Pendu,et al.  Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals , 2002, Gastroenterology.

[44]  Ian N. Clarke,et al.  Norwalk-like viruses , 2002 .

[45]  M G Rossmann,et al.  X-ray crystallographic structure of the Norwalk virus capsid. , 1999, Science.

[46]  R. Glass,et al.  Identification of a distinct common strain of "Norwalk-like viruses" having a global distribution. , 1999, The Journal of infectious diseases.

[47]  J. Vinjé,et al.  The incidence and genetic variability of small round-structured viruses in outbreaks of gastroenteritis in The Netherlands. , 1997, The Journal of infectious diseases.